Paul E. Zarek

Array ( [id] => 7696052 [patent_doc_number] => 20110230538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'PHARMACEUTICAL FOR USE IN THE TREATMENT OF URETEROLITHIASIS' [patent_app_type] => utility [patent_app_number] => 13/086040 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3589 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230538.pdf [firstpage_image] =>[orig_patent_app_number] => 13086040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768071 [patent_doc_number] => 20130096109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PYRIDONE DERIVATIVE HAVING INTEGRASE INHIBITORY ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/639454 [patent_app_country] => US [patent_app_date] => 2011-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14304 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951207 [patent_doc_number] => 08999993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Radioprotector compounds and methods' [patent_app_type] => utility [patent_app_number] => 13/640188 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 59383 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959595 [patent_doc_number] => 20110183982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS' [patent_app_type] => utility [patent_app_number] => 13/080425 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52917 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183982.pdf [firstpage_image] =>[orig_patent_app_number] => 13080425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808056 [patent_doc_number] => 20120059010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'ALPHA-HELIX MIMETICS AND METHODS RELATING TO THE TREATMENT OF FIBROSIS' [patent_app_type] => utility [patent_app_number] => 13/073176 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8387 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059010.pdf [firstpage_image] =>[orig_patent_app_number] => 13073176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016647 [patent_doc_number] => 20110224177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS' [patent_app_type] => utility [patent_app_number] => 13/047039 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10446 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224177.pdf [firstpage_image] =>[orig_patent_app_number] => 13047039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768155 [patent_doc_number] => 20130096192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'NOVEL COMPOSITONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/634170 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8457 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567190 [patent_doc_number] => 20120329761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'USE OF TIGECYCLINE FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/582842 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13540 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163150 [patent_doc_number] => 20110160190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/040614 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31931 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160190.pdf [firstpage_image] =>[orig_patent_app_number] => 13040614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382221 [patent_doc_number] => 20120225850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Steroidal antitubercular compounds' [patent_app_type] => utility [patent_app_number] => 13/037494 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5080 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13037494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102740 [patent_doc_number] => 20110166233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/034201 [patent_app_country] => US [patent_app_date] => 2011-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13635 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166233.pdf [firstpage_image] =>[orig_patent_app_number] => 13034201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421868 [patent_doc_number] => 08278356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Phloroglucinol derivatives having selectin ligand activity' [patent_app_type] => utility [patent_app_number] => 13/032760 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421868 [patent_doc_number] => 08278356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Phloroglucinol derivatives having selectin ligand activity' [patent_app_type] => utility [patent_app_number] => 13/032760 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421868 [patent_doc_number] => 08278356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Phloroglucinol derivatives having selectin ligand activity' [patent_app_type] => utility [patent_app_number] => 13/032760 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421868 [patent_doc_number] => 08278356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Phloroglucinol derivatives having selectin ligand activity' [patent_app_type] => utility [patent_app_number] => 13/032760 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048705 [patent_doc_number] => 20110207764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'CYCLOPOLYSACCHARIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/032159 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7374 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207764.pdf [firstpage_image] =>[orig_patent_app_number] => 13032159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063473 [patent_doc_number] => 20110245287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Hybrid Opioid Compounds and Compositions' [patent_app_type] => utility [patent_app_number] => 13/024298 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20931 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245287.pdf [firstpage_image] =>[orig_patent_app_number] => 13024298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660107 [patent_doc_number] => 20130040935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'CYCLIC KETO-ENOLS FOR THERAPY' [patent_app_type] => utility [patent_app_number] => 13/578914 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 77442 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398483 [patent_doc_number] => 08268862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Sirtuin modulating compounds' [patent_app_type] => utility [patent_app_number] => 13/012775 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26416 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413641 [patent_doc_number] => 08697678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Anaesthetic formulation' [patent_app_type] => utility [patent_app_number] => 13/574201 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 13110 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574201 [rel_patent_id] =>[rel_patent_doc_number] =>)